Faron Pharmaceuticals hosts live R&D Day webcast on bexmarilimab progress

PUBT · 2d ago
Faron Pharmaceuticals hosts live R&D Day webcast on bexmarilimab progress
  • Faron Pharmaceuticals will host an R&D Day webcast on Oct. 8, 2026, starting 8:00 a.m. EDT.
  • Event focus includes clinical progress for lead immunotherapy candidate bexmarilimab, including the BEXERA trial in hematological cancers.
  • Agenda also covers expansion into solid tumors, pipeline strategy, market opportunity, management priorities, panel Q&A.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.